Maximus, Inc. (NYSE:MMS) Shares Sold by Cetera Investment Advisers

Cetera Investment Advisers lowered its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 51.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,272 shares of the health services provider's stock after selling 4,491 shares during the period. Cetera Investment Advisers' holdings in Maximus were worth $319,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of MMS. Captrust Financial Advisors bought a new position in shares of Maximus during the fourth quarter valued at approximately $276,000. Algert Global LLC lifted its position in shares of Maximus by 12.1% in the fourth quarter. Algert Global LLC now owns 187,017 shares of the health services provider's stock valued at $13,961,000 after acquiring an additional 20,215 shares in the last quarter. Freestone Grove Partners LP purchased a new position in Maximus in the 4th quarter worth approximately $1,718,000. AQR Capital Management LLC boosted its position in shares of Maximus by 189.1% during the fourth quarter. AQR Capital Management LLC now owns 423,298 shares of the health services provider's stock worth $31,599,000 after acquiring an additional 276,859 shares during the last quarter. Finally, Northern Trust Corp grew its position in shares of Maximus by 13.2% during the fourth quarter. Northern Trust Corp now owns 815,133 shares of the health services provider's stock valued at $60,850,000 after purchasing an additional 94,858 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

Insider Activity at Maximus

In related news, Director Gayathri Rajan sold 7,913 shares of Maximus stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the transaction, the director now owns 14,205 shares in the company, valued at approximately $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This represents a 11.88% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Maximus Trading Down 1.0%

NYSE:MMS traded down $0.70 during midday trading on Wednesday, hitting $71.05. The stock had a trading volume of 397,931 shares, compared to its average volume of 563,892. The company has a market capitalization of $4.00 billion, a price-to-earnings ratio of 15.28 and a beta of 0.61. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.97. The stock has a 50-day moving average of $70.15 and a 200 day moving average of $71.44.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The business had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same period last year, the business earned $1.57 EPS. The company's revenue was up 1.0% compared to the same quarter last year. As a group, sell-side analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Saturday, May 31st. Investors of record on Thursday, May 15th were given a dividend of $0.30 per share. The ex-dividend date was Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.69%. Maximus's dividend payout ratio is presently 23.86%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.